Concordance of RT-qPCR with immunohistochemistry and its beneficial role in breast cancer subtypingYilun Li, Li Ma, Ting‐Hao Chen et al.|Medicine|2023Cited by 4
Development and validation of a novel HER2RI assay for predicting the risk of recurrence and survival in HER2-positive early breast cancerYi‐Kun Kang, Peng Yuan, Keyu Chen et al.|Research Square|2022Cited by 0
Differences of prediction performances by multigene assays in patients with breast cancer with distinct genetic backgrounds.Fei Xing, Zhongyu Lu, Ting‐Hao Chen et al.|Journal of Clinical Oncology|2023Cited by 0